About this episode
Last year, the FDA approved a treatment for sickle cell disease using a revolutionary new gene editing technology called CRISPR. Rachel Haurwitz conducted pioneering research on CRISPR as a graduate student. Now she’s the co-founder and CEO of Caribou Biosciences. Rachel's problem is this: How can you improve CRISPR and use it to engineer human immune cells to fight cancer?
See omnystudio.com/listener for privacy information.
Get every episode summarized
Each time What's Your Problem? publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from What's Your Problem?
Can a Robot Kill Fish Humanely?
What's Your Problem?
Using Satellites to Prevent Famines
What's Your Problem?
The Quantum Shift in Biomedical Discovery from Smart Talks with IBM
What's Your Problem?
Can We Slow Down Aging?
What's Your Problem?